Nuvation Bio Inc.

19 clinical trials · Sponsor

Record	Firm	Date
Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease (NCT07703436)	Nuvation Bio Inc.	2027-03-01
Safety and Efficacy Study of Safusidenib in Participants With Grade 2 IDH1-Mutant Glioma (NCT07712757)	Nuvation Bio Inc.	2027-03-01
Study on the Effect of Famotidine on Pharmacokinetics of Taletrectinib (NCT07742384)	Nuvation Bio Inc.	2026-08-01
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV) (NCT07154706)	Nuvation Bio Inc.	2025-08-21
A Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients (NCT06564324)	Nuvation Bio Inc.	2024-11-27
Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors (NCT06334432)	Nuvation Bio Inc.	2024-03-14
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance) (NCT05303519)	Nuvation Bio Inc.	2023-06-05
Study the Effect of Omeprazole on AB-106 Pharmacokinetics (NCT05609929)	Nuvation Bio Inc.	2022-11-02
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC (NCT05191017)	Nuvation Bio Inc.	2022-09-01
Study of NUV-422 in Combination With Fulvestrant in Patients With HR+HER2- aBC (NCT05191004)	Nuvation Bio Inc.	2022-09-01
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors (NCT05252390)	Nuvation Bio Inc.	2022-03-29
Taletrectinib Phase 2 Global Study in ROS1 Positive NSCLC (NCT04919811)	Nuvation Bio Inc.	2021-09-01
A Study on the Effect of AB-106 on the Pharmacokinetics of Digoxin (NCT05357911)	Nuvation Bio Inc.	2021-07-13
Phase II Study of AB-106 to Treat Patients With Solid Tumors With NTRK Gene Fusion (NCT04617054)	Nuvation Bio Inc.	2021-06-01
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors (NCT04541225)	Nuvation Bio Inc.	2020-12-08
A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion Gene (NCT04395677)	Nuvation Bio Inc.	2020-07-07

Track Nuvation Bio Inc. automatically

Every clearance here is in the API, with alerts when new ones post.